GB201316766D0 - Macrophage Imaging - Google Patents

Macrophage Imaging

Info

Publication number
GB201316766D0
GB201316766D0 GBGB1316766.3A GB201316766A GB201316766D0 GB 201316766 D0 GB201316766 D0 GB 201316766D0 GB 201316766 A GB201316766 A GB 201316766A GB 201316766 D0 GB201316766 D0 GB 201316766D0
Authority
GB
United Kingdom
Prior art keywords
macrophage imaging
macrophage
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1316766.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare UK Ltd
Original Assignee
GE Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare UK Ltd filed Critical GE Healthcare UK Ltd
Priority to GBGB1316766.3A priority Critical patent/GB201316766D0/en
Publication of GB201316766D0 publication Critical patent/GB201316766D0/en
Priority to PCT/EP2014/069839 priority patent/WO2015040087A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
GBGB1316766.3A 2013-09-20 2013-09-20 Macrophage Imaging Ceased GB201316766D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1316766.3A GB201316766D0 (en) 2013-09-20 2013-09-20 Macrophage Imaging
PCT/EP2014/069839 WO2015040087A1 (en) 2013-09-20 2014-09-17 Macrophage imaging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1316766.3A GB201316766D0 (en) 2013-09-20 2013-09-20 Macrophage Imaging

Publications (1)

Publication Number Publication Date
GB201316766D0 true GB201316766D0 (en) 2013-11-06

Family

ID=49553184

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1316766.3A Ceased GB201316766D0 (en) 2013-09-20 2013-09-20 Macrophage Imaging

Country Status (2)

Country Link
GB (1) GB201316766D0 (en)
WO (1) WO2015040087A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0818738D0 (en) * 2008-10-13 2008-11-19 Ge Healthcare Ltd Imaging neuroflammation
GB0905328D0 (en) * 2009-03-27 2009-05-13 Ge Healthcare Ltd Indole derivatives
GB201016038D0 (en) * 2010-09-24 2010-11-10 Ge Healthcare Ltd In vivo imaging method
GB201016411D0 (en) * 2010-09-30 2010-11-10 Ge Healthcare Ltd In vivo imaging method for cancer
US9498546B2 (en) * 2012-03-14 2016-11-22 The Johns Hopkins University Synthesis and application of novel imaging agents conjugated to DPA 713 analogs for imaging inflammation

Also Published As

Publication number Publication date
WO2015040087A1 (en) 2015-03-26

Similar Documents

Publication Publication Date Title
DK3088517T3 (en) Humant anti-il-33-neutraliserende monoklonalt antistof
EP2951642A4 (en) Omnistereo imaging
HK1219855A1 (en) Otoscope
GB201315248D0 (en) Imaging
GB201304149D0 (en) Ultrasound imaging
EP2866445A4 (en) Imaging device
HK1219856A1 (en) Otoscope
HK1219857A1 (en) Otoscope
HK1217316A1 (en) Photo-alignable object
EP3041222A4 (en) Imaging device
PL3011321T3 (en) Coded-aperture x-ray imaging
GB2510372B (en) Imaging sensor
EP2950517A4 (en) Imaging device
GB201310476D0 (en) Scintillator
GB2530691B (en) Radiation imaging
EP2975836A4 (en) Imaging device
GB201302036D0 (en) Diagnosis
IL245156A0 (en) Bias-variant photomultiiplier tube
EP3051155A4 (en) Movement unit
GB201304071D0 (en) Teds -1x
GB201316766D0 (en) Macrophage Imaging
HK1194952A1 (en) Otoscope
GB201317984D0 (en) Imaging surfaces
SG2013011275A (en) Imaging solution
GB201410767D0 (en) Connection arrangement

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)